Delivery Order SPE2DB24D2010-SPE2DB24FZSE3
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. The contract has a potential value of $4,734.61 and a completion date of March 8, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract worth $3,451.95 by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $15,047.26 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,120.33 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. The $12,203.58 contract has a performance period through March 5, 2024. The award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a period of performance through December 31, 2025, which serves as...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $9,344.10 firm fixed price delivery order from the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies in support of Department of Defense military...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,054.39 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML pharmaceuticals. This delivery order falls under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical...
- This is a Delivery Order worth $18,263.40 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The contract has an ultimate completion date of April 16, 2024 and is a Firm Fixed Price type. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $5,556.34 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. This delivery order has a completion date of February 9, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,822.63 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide COSENTYX SNRDY 300MG DOSE-2PENML. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract with DLA worth up to $999,999,999.00...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB24FZSE3Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a potential value of $4,108.03. The contract has a completion date of March 5, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 3/4/24 |